Supplementary Figure 3: Knockdown of SMYD2 attenuates monomethylation (meK133) of β-catenin in nucleus.
Significant reduction of mono-methylated (meK133) β-catenin was observed in the nuclei of SNU449 (a) and SNU475 (b) cells by knockdown of SMYD2. Cells were transfected with siNC (control) or siSMYD2 (SMYD2#2). After 48h-incubation with siRNAs, cells were fixed with 4% paraformaldehyde, and stained with an anti-α-tubulin antibody (Alexa Fluor ® 594, red), anti-meK133-β-catenin antibody (Alexa Fluor ® 488, green) and 4',6'-diamidine-2'-phenylindole dihydrochloride (DAPI, blue). www.impactjournals.com/oncotarget SNU449 and SNU475 cells were transfected with Flag-Mock, Flag-WT-β-catenin or Flag-K133A-β-catenin. DMSO (control) or SMYD2-specific inhibitor, LLY-507 (1uM) was added in the cells transfected with Flag-WT-β-catenin. Cell viability assays were performed at day 3 and day 5. Significant increase of the number of viable cells was observed in cells transfected with Flag-WT-β-catenin plasmid while significant decrease of the number of viable cells was observed in cells transfected with Flag-K133A-β-catenin plasmid, compared with those transfected by Flag-Mock at day 5. In addition, growth-promoting effect of WT-β-catenin was completely diminished by addition of LLY-507. Statistical analyses were performed using unpaired Student's t-test (two groups). The asterisks indicate statistical significance; *, **, and *** indicate p-value of <0.05, <0.01 and <0.005, respectively. Error bars indicate values of one standard deviation (n=3). 
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